Analyst Mitchell Kapoor from H.C. Wainwright reiterated a Hold rating on Zura Bio (ZURA – Research Report) and keeping the price target ...

Additionally, IK-595 shows potential for synergistic effects with various anticancer agents, enhancing its therapeutic prospects. Although the removal of IK-930 has impacted the stock’s valuation, ...

In a recent article, researchers synthesized and characterized amino acid-functionalized magnetite nanoparticles, exploring ...

The global periodontal disease treatment market is projected to reach USD 3.63 billion by 2030 from USD 2.58 billion in 2024, ...

In the first half of 2025, Werewolf expects to provide an update on the WTX-124 clinical development program, including data ...

Additional preclinical data demonstrate INDUKINETM molecules' anti-tumor potency with distinct immune activation profiles ...

Liposomal Doxorubicin Market Liposomal Doxorubicin Market Dublin, Nov. 07, 2024 (GLOBE NEWSWIRE) -- The "Liposomal ...

Bilirubin, the byproduct of hemoprotein breakdown, particularly hemoglobin, is a critical marker in diagnosing, prognosing, ...

Werewolf Therapeutics, Inc. (the“Company” or“Werewolf”) (Nasdaq: HOWL), an innovative biopharmaceutical company pioneering the development of conditionally activated therapeutics engineered to ...

In a paper published in the journal Pharmaceuticals, researchers developed metformin carbon quantum dots (MetCQDs) to improve ...